Article type
Abstract
Background
Antimalarial resistance to artemisinin and related drugs presents a significant challenge in parts of Africa, including Uganda, Rwanda, and Eritrea. The MARC SE-Africa (Mitigating Antimalarial Resistance Consortium in Southern and East Africa) project aims to address this challenge by bringing together stakeholders from academia, government, and non-governmental institutions. This consortium seeks to translate evidence of artemisinin and related drug resistance into actionable insights for malaria policy and practice.
Objectives
Quantify and map the structure of the malaria network and stakeholders in Eastern and Southern Africa, identify strengths and gaps in connections across the network, both within organizations and among individuals, to Identify barriers and facilitators for evidence uptake within the network and to Identify crucial network information for improving knowledge sharing and uptake between organizations and groups.
Methodology
Employing a case study approach guided by social network analysis framework, we will map and identify network actors, analyze relationships, and visualize these actors and connections. Data will be collected through document reviews, in-depth interviews, and a survey targeting malaria practitioners in or connected to the region. The data will be collated, analyzed, and presented using Gephi v. 0.9.6 software.
Expected Results
This analysis will provide insights into significant stakeholders, connections, and actions impacting efforts to mitigate artemisinin and partner drug resistance. We will categorize actors and relationships based on their roles in the project, informing stakeholder engagement strategies and risk mitigation plans.
Conclusion
The findings from this Social Network Analysis will guide the MARC SE-Africa project in effectively engaging stakeholders, facilitating knowledge sharing, and implementing surveillance measures for antimalarial resistance. By identifying key actors and relationships, we aim to enhance the success of efforts to address this critical public health issue in Eastern and Southern Africa.
Relevance to patients: The study will facilitate sharing of anti malarial drug resistance evidence to policymakers and support them to make informed decisions which will benefit the public to fight malaria.
Antimalarial resistance to artemisinin and related drugs presents a significant challenge in parts of Africa, including Uganda, Rwanda, and Eritrea. The MARC SE-Africa (Mitigating Antimalarial Resistance Consortium in Southern and East Africa) project aims to address this challenge by bringing together stakeholders from academia, government, and non-governmental institutions. This consortium seeks to translate evidence of artemisinin and related drug resistance into actionable insights for malaria policy and practice.
Objectives
Quantify and map the structure of the malaria network and stakeholders in Eastern and Southern Africa, identify strengths and gaps in connections across the network, both within organizations and among individuals, to Identify barriers and facilitators for evidence uptake within the network and to Identify crucial network information for improving knowledge sharing and uptake between organizations and groups.
Methodology
Employing a case study approach guided by social network analysis framework, we will map and identify network actors, analyze relationships, and visualize these actors and connections. Data will be collected through document reviews, in-depth interviews, and a survey targeting malaria practitioners in or connected to the region. The data will be collated, analyzed, and presented using Gephi v. 0.9.6 software.
Expected Results
This analysis will provide insights into significant stakeholders, connections, and actions impacting efforts to mitigate artemisinin and partner drug resistance. We will categorize actors and relationships based on their roles in the project, informing stakeholder engagement strategies and risk mitigation plans.
Conclusion
The findings from this Social Network Analysis will guide the MARC SE-Africa project in effectively engaging stakeholders, facilitating knowledge sharing, and implementing surveillance measures for antimalarial resistance. By identifying key actors and relationships, we aim to enhance the success of efforts to address this critical public health issue in Eastern and Southern Africa.
Relevance to patients: The study will facilitate sharing of anti malarial drug resistance evidence to policymakers and support them to make informed decisions which will benefit the public to fight malaria.